Category: pnas

Lawyers call libel suit against journal and critic “lawless” but “well written”

Mark Jacobson

A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.”

Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free speech at Popehat, told us:

It’s not incompetently drafted, but it’s clearly vexatious and intended to silence dissent about an alleged scientist’s peer-reviewed article.

Scientists have publicly bemoaned the suit’s existence, as reported by several outlets, including Mashable and Nature. Mark Jacobson, an engineering professor at Stanford, has alleged that he was defamed in a June article published in the Proceedings of the National Academy of Sciences (PNAS), which was critical of a 2015 paper co-authored by Jacobson in the same journal. In a complaint filed Sept. 29 in the Superior Court of the District of Columbia, Jacobson accused the journal’s publisher, the National Academy of Sciences, and the paper’s first author, Christopher Clack, an executive at a renewable energy analysis firm, of libel.

White told us that there are several pitfalls that could trip up the lawsuit, including a DC law that allows defendants an early opportunity to ask the court to dismiss cases muzzling free speech and recover attorneys’ fees. But another attorney said the complaint should at least clear the lowest hurdle in the way of getting to trial. Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”

Caught Our Notice: Investigation finds “accidental mistakes” in PNAS stem cell paper

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of 1,000 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at [email protected].

Title: Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation 

What caught our attention: Continue reading Caught Our Notice: Investigation finds “accidental mistakes” in PNAS stem cell paper

Are rich people meaner? While trying to find out, two teams find errors in each other’s work

Is having money linked to bad behavior?

A high profile paper published in 2012 in the Proceedings of the National Academy of Sciences (PNAS) set out to answer that question — and found that yes, the more money people have, the more likely they are to lie, cheat, and steal. And the greedier they are, the worse they behave. But when a more recent paper tried to replicate some of those findings, it couldn’t.

It turns out, both the original paper and the paper that tried to replicate it contained errors. Although neither appear to affect the main conclusions, the authors of the 2016 replication recently issued a correction; the error in the 2012 paper was initially deemed too insignificant to correct, but the journal has decided to revisit the idea of issuing a correction.

A representative of PNAS told us that the replication paper — and reporting by Retraction Watch — is the reason why: Continue reading Are rich people meaner? While trying to find out, two teams find errors in each other’s work

Third retraction for former rising star found guilty of misconduct

A once-prominent researcher in the field of infectious disease — who was found guilty of misconduct last year— has had a third paper retracted, a 2006 article in PNAS.

Last year, the University of Dundee in Scotland found that Robert Ryan had committed research misconduct, which included misrepresenting clinical data and duplicating images in a dozen different publications. After a failed attempt to appeal the decision, Ryan resigned.

In April, we covered Ryan’s first two retractions – a 2012 paper in Molecular Microbiology, which cited image errors, and a 2011 paper in Journal of Bacteriology, which cited image duplication.

Now, PNAS has retracted a 2006 paper, which cites potential image duplication as well as “irregularities” in the data.

Here’s the retraction notice for “Cell–cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover:”

Continue reading Third retraction for former rising star found guilty of misconduct

Can we do math unconsciously? Replicators of a prominent 2012 study have some doubts

In 2012, news media were abuzz with a new finding from PNAS: Authors based in Israel had found evidence that our brains can unconsciously process more than we thought — including basic math and reading.  In other words, the authors claimed people could read and do math without even knowing what they were doing.

With such a major development in the field of consciousness research, other groups quickly got to work trying to replicate the findings. Those efforts have taken some twists and turns — including a recent retraction of a replication paper that was, itself, not reproducible (which is not something we see every day). But overall, five years after the initial, remarkable result, the replication efforts are calling it into question.

According to Pieter Moors at KU Leuven, a researcher in this field:

Continue reading Can we do math unconsciously? Replicators of a prominent 2012 study have some doubts

Dear journals: Clean up your act. Regards, Concerned Biostatistician

Romain-Daniel Gosselin

Recently, a biostatistician sent an open letter to editors of 10 major science journals, urging them to pay more attention to common statistical problems with papers. Specifically, Romain-Daniel Gosselin, Founder and CEO of Biotelligences, which trains researchers in biostatistics, counted how many of 10 recent papers in each of the 10 journals contained two common problems: omitting the sample size used in experiments, as well as the tests used as part of the statistical analyses. (Short answer: Too many.) Below, we have reproduced his letter.

Dear Editors and Colleagues,

I write this letter as a biologist and instructor of biostatistics, concerned about the disregard for statistical reporting that is threatening scientific reproducibility. I hereby urge you to spearhead the strict application of existing guidelines on statistical reporting. Continue reading Dear journals: Clean up your act. Regards, Concerned Biostatistician

A diabetes researcher sued his former employer for defamation. Here’s the story.

Franck Mauvais-Jarvis

The last decade hasn’t exactly been drama-free for Franck Mauvais-Jarvis, head of the Diabetes Research Program at Tulane University.

After being accused of falsifying three figures in a submitted manuscript, Mauvais-Jarvis sued his accusers and officials at his former employer — Northwestern University — for defamation and conspiracy in 2011.

In 2014, a judge dismissed the suit. We wish we could tell you more details about it—such as what the university’s misconduct investigation found, or how the lawsuit was concluded—but they remain shrouded in mystery. What we know is based on court records from the lawsuit, which we recently obtained through an unrelated public records request. Even without all the details, it’s a long, sordid tale, involving a lot of finger-pointing and allegations of misconduct.

In 2008, a former research technician in the lab of Mauvais-Jarvis, then an associate professor of medicine at Northwestern University, raised concerns of fabrication in two figures in a paper on the regulation of insulin synthesis that had been submitted the Journal of Biological Chemistry. An inquiry committee at the university unanimously concluded that research misconduct charges against Mauvais-Jarvis were not credible.

But then a third figure in the manuscript was found to be “inaccurate,” and the university initiated a second inquiry. That’s when Mauvais-Jarvis — whose papers have been cited more than 2,000 times, according to Clarivate Analytics’ Web of Science, formerly part of Thomson Reuters — initiated a lawsuit. Continue reading A diabetes researcher sued his former employer for defamation. Here’s the story.

Journals retract paper, flag two others by cancer doc under investigation

Carlo Croce

This weekend, Carlo Croce had some reprieve from the misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times) and that have prompted his university to re-open an investigation. On Sunday, he received a prestigious award from the American Association for Cancer Research, honoring his work.

But the moment may have been short-lived. Today, Croce received two expressions of concern (EOCs) from PNAS for two well-cited papers published over a decade ago, on which Croce — chair of the Department of Cancer Biology and Genetics at The Ohio State University (OSU) — is last author. The two EOCs cite concerns over duplicated bands. What’s more, another journal recently decided to retract one of his papers, citing figures that didn’t represent the results of the experiments.

PNAS chose to issue EOCs, rather than retractions or corrections, because the authors didn’t agree that the bands were duplicated, according to executive editor Diane Sullenberger. She explained how the journal learned of the issues with the two papers: Continue reading Journals retract paper, flag two others by cancer doc under investigation

What leads to bias in the scientific literature? New study tries to answer

By now, most of our readers are aware that some fields of science have a reproducibility problem. Part of the problem, some argue, is the publishing community’s bias toward dramatic findings — namely, studies that show something has an effect on something else are more likely to be published than studies that don’t.

Many have argued that scientists publish such data because that’s what is rewarded — by journals and, indirectly, by funders and employers, who judge a scientist based on his or her publication record. But a new meta-analysis in PNAS is saying it’s a bit more complicated than that.

In a paper released today, researchers led by Daniele Fanelli and John Ioannidis — both at Stanford University — suggest that the so-called “pressure-to-publish” does not appear to bias studies toward larger so-called “effect sizes.” Instead, the researchers argue that other factors were a bigger source of bias than the pressure-to-publish, namely the use of small sample sizes (which could contain a skewed sample that shows stronger effects), and relegating studies with smaller effects to the “gray literature,” such as conference proceedings, PhD theses, and other less publicized formats.

However, Ferric Fang of the University of Washington — who did not participate in the study — approached the findings with some caution:

Continue reading What leads to bias in the scientific literature? New study tries to answer

Another correction for prominent cancer researcher who’s dodged accusations for decades

The chair of a biology department who has faced years of misconduct accusations has taken another hit—a lengthy correction due to text “overlap” between one of his PNAS papers and six other articles.

According to the correction, a reader contacted the journal to notify the editors that text and sentences in multiple sections of the 2015 paper — on which Carlo Croce is last author — were lifted from other sources without quotation marks.

This is the second correction for Croce in PNAS regarding overlap issues in just the last few weeks—the first was published on March 7 (see here). In both instances, PNAS did not call the textual similarities plagiarism, but the notice details multiple instances of overlap.

Croce, the chair of the department of cancer biology and genetics at The Ohio State University (OSU), is no stranger to controversy.

Continue reading Another correction for prominent cancer researcher who’s dodged accusations for decades